BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9210345)

  • 1. Influence of aeration and carbon source on production of microcin B17 by Escherichia coli ZK650.
    Fang A; Demain AL
    Appl Microbiol Biotechnol; 1997 May; 47(5):547-53. PubMed ID: 9210345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of microcin B17 formation in Escherichia coli ZK650 by limitation of oxygen and glucose is independent of glucose consumption rate.
    Gao Q; Fang A; Demain AL
    J Ind Microbiol Biotechnol; 2001 Jun; 26(6):341-4. PubMed ID: 11571616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relief from glucose interference in microcin B17 biosynthesis by growth in a rotating-wall bioreactor.
    Fang A; Pierson DL; Mishra SK; Demain AL
    Lett Appl Microbiol; 2000 Jul; 31(1):39-41. PubMed ID: 10886612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of simulated microgravity and shear stress on microcin B17 production by Escherichia coli and on its excretion into the medium.
    Fang A; Pierson DL; Koenig DW; Mishra SK; Demain AL
    Appl Environ Microbiol; 1997 Oct; 63(10):4090-2. PubMed ID: 9327574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase.
    Yorgey P; Davagnino J; Kolter R
    Mol Microbiol; 1993 Aug; 9(4):897-905. PubMed ID: 8231817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shear stress enhances microcin B17 production in a rotating wall bioreactor, but ethanol stress does not.
    Gao Q; Fang A; Pierson DL; Mishra SK; Demain AL
    Appl Microbiol Biotechnol; 2001 Aug; 56(3-4):384-7. PubMed ID: 11549006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents.
    Collin F; Maxwell A
    J Mol Biol; 2019 Aug; 431(18):3400-3426. PubMed ID: 31181289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary metabolism in simulated microgravity.
    Demain AL; Fang A
    Chem Rec; 2001; 1(4):333-46. PubMed ID: 11893073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor.
    Yorgey P; Lee J; Kördel J; Vivas E; Warner P; Jebaratnam D; Kolter R
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4519-23. PubMed ID: 8183941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of pmbA, an Escherichia coli chromosomal gene required for the production of the antibiotic peptide MccB17.
    Rodríguez-Sáinz MC; Hernández-Chico C; Moreno F
    Mol Microbiol; 1990 Nov; 4(11):1921-32. PubMed ID: 2082149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of iron on microcin 25 production.
    Salomón RA; Farías RN
    FEMS Microbiol Lett; 1994 Sep; 121(3):275-9. PubMed ID: 7926681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting microcin E492 production.
    de Lorenzo V
    J Antibiot (Tokyo); 1985 Mar; 38(3):340-5. PubMed ID: 3924870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mprA, an Escherichia coli gene that reduces growth-phase-dependent synthesis of microcins B17 and C7 and blocks osmoinduction of proU when cloned on a high-copy-number plasmid.
    del Castillo I; Gómez JM; Moreno F
    J Bacteriol; 1990 Jan; 172(1):437-45. PubMed ID: 2152912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cloning and analysis of genetic determinants determining the production of microcin B2 and B27].
    Basiuk EI; Bezrukov VM; Lipasova VA; Khmel' IA
    Genetika; 1994 Jun; 30(6):731-9. PubMed ID: 7958785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The highly conserved TldD and TldE proteins of Escherichia coli are involved in microcin B17 processing and in CcdA degradation.
    Allali N; Afif H; Couturier M; Van Melderen L
    J Bacteriol; 2002 Jun; 184(12):3224-31. PubMed ID: 12029038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and regioselectivity of peptide-to-heterocycle conversions by microcin B17 synthetase.
    Belshaw PJ; Roy RS; Kelleher NL; Walsh CT
    Chem Biol; 1998 Jul; 5(7):373-84. PubMed ID: 9662507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo processing and antibiotic activity of microcin B17 analogs with varying ring content and altered bisheterocyclic sites.
    Sinha Roy R; Kelleher NL; Milne JC; Walsh CT
    Chem Biol; 1999 May; 6(5):305-18. PubMed ID: 10322125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An E. coli promoter induced by the cessation of growth.
    Connell N; Han Z; Moreno F; Kolter R
    Mol Microbiol; 1987 Sep; 1(2):195-201. PubMed ID: 2835580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth phase and ompR regulation of transcription of microcin B17 genes.
    Hernández-Chico C; San Millán JL; Kolter R; Moreno F
    J Bacteriol; 1986 Sep; 167(3):1058-65. PubMed ID: 3017916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites.
    Zamble DB; Miller DA; Heddle JG; Maxwell A; Walsh CT; Hollfelder F
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7712-7. PubMed ID: 11427730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.